# Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence

> **NCT02070575** · — · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 200 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** blood draw

## Key facts

- **NCT ID:** NCT02070575
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-20
- **Primary completion:** 2023-10-18
- **Final completion:** 2023-10-18
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02070575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02070575, "Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02070575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*